Curve Therapeutics
PrivateLast Round
Series A
Feb 27, 2024
Total Funding Raised
$62.92M
Company Overview
Curve Therapeutics is a biotechnology company that develops a drug discovery platform for creating macrocycle-derived therapeutics to treat cancer, immunology, and inflammation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curve Therapeutics Comparables
Compare Curve Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Orbis Medicines | 88% | |
| BRT Biotechnologies | 86% | |
| Insamo | 84% | |
Curve Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 27, 2024 | ||||
| Seed | Jul 31, 2020 | ||||
| Seed | Jun 27, 2019 |
Curve Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Epidarex Capital | Seed, Series A |
| Advent Life Sciences | Series A, Seed |
| British Patient Capital | Series A |
| British Patient Capital | Series A |
| Pfizer Ventures | Series A |
| Pfizer | Series A |
| Columbus Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2025
Co-Founder recognized with the Interdisciplinary Prize by the Royal Society of Chemistry.
- Jul 31, 2020
$6M round led by Advent Life Sciences and Epidarex Capital.
Curve Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Curve Therapeutics's valuation, stock price, and market status.